Two Sigma Investments’s Neurogene NGNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$306K Buy
20,497
+9,653
+89% +$144K ﹤0.01% 2737
2025
Q1
$127K Sell
10,844
-9,785
-47% -$115K ﹤0.01% 2873
2024
Q4
$472K Buy
+20,629
New +$472K ﹤0.01% 2504
2024
Q2
Sell
-3,961
Closed -$202K 3138
2024
Q1
$202K Buy
+3,961
New +$202K ﹤0.01% 2641
2023
Q4
Sell
-8,552
Closed -$135K 3210
2023
Q3
$135K Sell
8,552
-2,008
-19% -$31.7K ﹤0.01% 2633
2023
Q2
$175K Sell
10,560
-775
-7% -$12.9K ﹤0.01% 2591
2023
Q1
$159K Sell
11,335
-3,617
-24% -$50.6K ﹤0.01% 2528
2022
Q4
$152K Sell
14,952
-2,205
-13% -$22.4K ﹤0.01% 2384
2022
Q3
$220K Buy
17,157
+1,533
+10% +$19.7K ﹤0.01% 2029
2022
Q2
$322K Buy
15,624
+3,425
+28% +$70.6K ﹤0.01% 1939
2022
Q1
$459K Buy
12,199
+4,404
+56% +$166K ﹤0.01% 2023
2021
Q4
$751K Buy
7,795
+1,784
+30% +$172K ﹤0.01% 1791
2021
Q3
$869K Buy
6,011
+4,056
+207% +$586K ﹤0.01% 1758
2021
Q2
$361K Buy
1,955
+1,211
+163% +$224K ﹤0.01% 2065
2021
Q1
$183K Sell
744
-7,693
-91% -$1.89M ﹤0.01% 2182
2020
Q4
$2.38M Buy
8,437
+1,120
+15% +$316K 0.01% 1010
2020
Q3
$1.76M Buy
7,317
+2,807
+62% +$674K 0.01% 960
2020
Q2
$1.5M Buy
4,510
+2,576
+133% +$855K 0.01% 992
2020
Q1
$440K Buy
1,934
+1,249
+182% +$284K ﹤0.01% 1301
2019
Q4
$169K Sell
685
-2,633
-79% -$650K ﹤0.01% 2006
2019
Q3
$189K Sell
3,318
-1,287
-28% -$73.3K ﹤0.01% 1760
2019
Q2
$217K Sell
4,605
-1,490
-24% -$70.2K ﹤0.01% 1834
2019
Q1
$329K Sell
6,095
-576
-9% -$31.1K ﹤0.01% 1799
2018
Q4
$288K Sell
6,671
-735
-10% -$31.7K ﹤0.01% 1757
2018
Q3
$434K Buy
+7,406
New +$434K ﹤0.01% 1644